Certified Residential Medication Aide (CRMA) Optional Study Group (Remote) and Recertification Exam (Gardiner) Vaccinated Only

June 29, 2021

*This class is for vaccinated student only*

Two days: Exam plus study group $150; One day: Exam Only $95.
Day 1-study group, 8:30am – 12:00pm; Day 2-exam, 8:30am – 2:30pm

The exam is offered to participants with a current CRMA certification. The optional study group meets on a day prior to the exam.

COVID-19 Safety

All students must be COVID-19 vaccinated to attend live class days for NCI courses. If you have not previously submitted proof of vaccination to New Communities, please send a scanned copy of your vaccine record to Sharon Wyman, Training & Program Coordinator at swyman@newcomms.org.

If one positive case is confirmed at the student’s work facility or if the student has been in contact with a confirmed COVID case within two weeks of the class day, the student or their supervisor must notify Sharon Wyman, Training & Program Coordinator at swyman@newcomms.org and their class will be rescheduled.

To view additional ticket options, click the "Filter by Date" button and select more dates.


Details Price Qty
CRMA Recertification Exam & Study Group - June 7,10show details + $150.00 (USD)  
CRMA Recertification (Exam Only) - June 10show details + $95.00 (USD)  
CRMA Recertification Exam & Study Group - July 5,6show details + $150.00 (USD)  
CRMA Recertification (Exam Only) - July 6show details + $95.00 (USD)  
CRMA Recertification Exam & Study Group - November 1,2show details + $150.00 (USD)  
CRMA Recertification (Exam Only) - November 2show details + $95.00 (USD)  

  • June 7, 2022
    8:30 AM - 12:30 PM
  • June 10, 2022
    8:30 AM - 2:30 PM
  • July 5, 2022
    8:30 AM - 12:30 PM
  • July 6, 2022
    8:30 AM - 2:30 PM
  • November 1, 2022
    8:30 AM - 12:30 PM
  • November 2, 2022
    8:30 AM - 2:30 PM

Venue:  

Venue Phone: (207) 591-0751 x117

Address:
13 Plaisted Street, Gardiner, Maine, 04345, United States

Description:

Last modified: April 21, 2022

Comments are closed.